- PROFESSOR Psychiatry
- PROFESSOR Neurology
American Board of Psychiatry and Neurology
- Todd E. Feinberg, M.D. is Board Certified in both Neurology and Psychiatry and is a Professor of Psychiatry and Neurology at the Icahn School of Medicine Mount Sinai Medical Center. He was a graduate of Mount Sinai School of Medicine and completed residencies in Neurology and Psychiatry at Mount Sinai Hospital; a Behavioral Neurology Fellowship in the Department of Neurology at the University of Florida, Gainesville, and an NIH Post-Doctorate Fellowship in Neurophysiology at Mount Sinai School of Medicine. He currently serves as the Chief of the Yarmon Neurobehavior and Alzheimer’s Disease Center of Mount Sinai Beth Israel Medical Center, New York City, a program he initiated in 1986.His clinical and research interests include the diagnosis and treatment of Alzheimer’s disease and other dementias, and the interface between neurology and psychiatry. He is the author or editor of over 100 publications and his books include Behavioral Neurology and Neuropsychology (McGraw-Hill, 2003), What to do When the Doctor Says its Early-Stage Alzheimer’s (Fair Winds, 2005), The Lost Self: Pathologies of the Brain and Identity (Oxford, 2005) Altered Egos: How the Brain Creates the Self (Oxford, 2001) and most recently From Axons to Identity: Neurological Explorations of the Nature of the Self (W.W. Norton). He lectures widely in national and international venues and has twice delivered the keynote address at the National Academy of Neuropsychology and the keynote address at the 16th Congress of the Italian Society of Psychopathology (SOPSI), in Rome.
Nominated for a Gradiva Award for Best Theoretical Book
National Association for the Advancement of Psychoanalysis
2008 - 2014
New York Super Doctors
New York Times
2007 - 2014
“The Best Doctors”
New York Magazine
2000 - 2013
“Top Doctor” in Neurology
New York Metro Area, Castle Connolly Guide
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Feinberg did not report having any of the following types of financial relationships with industry during 2014 and/or 2015: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Mount Sinai Health System (MSHS) physicians - including those employed by MSHS - do not always participate in the same health plans in which MSHS hospitals or facilities participate.
Information regarding insurance participation and billing by this physician may be found on this page or obtained by contacting this provider directly.
Insurance plans that the Mount Sinai Health System hospitals or facilities participate in can be found on the Mount Sinai Health System website.
1st Avenue at 16th Street
New York, NY 10003